David J Kuter Selected Research

Stem Cell Transplantation

1/2009	New thrombopoietic growth factors.
9/2007	Successful treatment of pure red cell aplasia with autologous stem cell transplantation.
11/2002	Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Kuter Research Topics

Disease

57	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2024 - 10/2006
32	Thrombocytopenia (Thrombopenia) 02/2024 - 08/2002
25	Hemorrhage 02/2024 - 03/2009
14	Neoplasms (Cancer) 01/2022 - 01/2004
11	Thrombosis (Thrombus) 01/2021 - 01/2004
9	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2024 - 01/2020
6	Fatigue 05/2024 - 01/2021
6	Hemolysis 01/2023 - 01/2021
5	Liver Diseases (Liver Disease) 01/2022 - 07/2010
4	Anemia 01/2023 - 08/2002
4	COVID-19 01/2022 - 01/2020
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2010
4	Hepatitis C 02/2021 - 01/2011
4	Gaucher Disease (Gaucher's Disease) 01/2020 - 10/2011
3	Infections 01/2022 - 01/2004
3	Thromboembolism 01/2021 - 01/2009
3	Leukemia 12/2016 - 11/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2013 - 07/2010
2	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 02/2024
2	Hypertension (High Blood Pressure) 11/2023 - 01/2021
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023 - 01/2021
2	Chronic Disease (Chronic Diseases) 10/2022 - 12/2019
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 02/2021
2	Thrombocytosis (Thrombocythemia) 01/2021 - 10/2020
2	Hereditary Hemorrhagic Telangiectasia 01/2021 - 01/2020
2	Iron Overload 01/2021 - 01/2018
2	Thrombotic Thrombocytopenic Purpura 06/2020 - 02/2009
2	Disseminated Intravascular Coagulation 01/2020 - 11/2018
2	Critical Illness (Critically Ill) 01/2020 - 02/2006
2	Febrile Neutropenia 12/2017 - 10/2013
2	Fibrosis (Cirrhosis) 05/2013 - 11/2007
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2012 - 02/2005
2	Body Weight (Weight, Body) 10/2011 - 10/2006
2	Pathologic Complete Response 09/2007 - 12/2006
1	Cognitive Dysfunction 05/2024
1	Brain Concussion (Cerebral Concussion) 05/2024
1	Pre-Eclampsia (Preeclampsia) 11/2023
1	Purpura 11/2023
1	Diarrhea 11/2023
1	Migraine Disorders (Migraine) 01/2023
1	Atherosclerotic Plaque (Atheroma) 11/2022
1	Inflammation (Inflammations) 11/2022
1	Rheumatoid Arthritis 01/2022
1	Pain (Aches) 01/2022

Drug/Important Bio-Agent (IBA)

48	Inosine Triphosphate (ITP)IBA 05/2024 - 10/2006
25	romiplostim FDA Link 12/2021 - 02/2008
14	Thrombopoietin ReceptorsIBA 02/2021 - 02/2008
10	Thrombopoietin (c-mpl Ligand)IBA 12/2021 - 02/2008
7	eltrombopag FDA Link 12/2018 - 06/2007
6	sutimlimabIBA 03/2024 - 01/2021
6	AutoantibodiesIBA 02/2024 - 12/2006
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 11/2002
6	Reticulin (Reticular Fiber)IBA 05/2013 - 11/2007
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 03/2015
5	avatrombopagIBA 12/2023 - 06/2014
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 10/2020
5	serum P-component (CIt)IBA 01/2022 - 01/2011
5	Heparin (Liquaemin)FDA LinkGeneric 11/2018 - 01/2004
4	Complement System Proteins (Complement)IBA 01/2023 - 07/2020
4	AntibodiesIBA 01/2020 - 05/2005
3	Complement C1s (C1 Esterase)IBA 01/2023 - 01/2022
3	Immunoglobulin G (IgG)IBA 12/2022 - 05/2005
3	Rituximab (Mabthera)FDA Link 01/2020 - 04/2014
2	fostamatinibIBA 11/2023 - 01/2022
2	Syk KinaseIBA 11/2023 - 01/2022
2	Complement Inactivating AgentsIBA 01/2023 - 01/2021
2	BilirubinIBA 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2022
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2018
2	fibrin fragment D (D-dimer)IBA 12/2020 - 01/2020
2	AnticoagulantsIBA 01/2020 - 08/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 11/2018
2	von Willebrand FactorIBA 06/2019 - 02/2009
2	EnzymesIBA 01/2019 - 11/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2018 - 01/2004
2	Bortezomib (Velcade)FDA Link 04/2015 - 07/2009
2	miglustat (Zavesca)FDA Link 08/2013 - 10/2011
2	polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA 12/2011 - 12/2006
2	Linezolid (Zyvox)FDA Link 12/2003 - 08/2002
1	Prednisolone (Predate)FDA LinkGeneric 11/2023
1	neonatal Fc receptorIBA 11/2023
1	Polysaccharides (Glycans)IBA 11/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	LipidsIBA 11/2022
1	givosiranIBA 01/2022
1	Hemin (Panhematin)FDA Link 01/2022

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2022 - 11/2002
16	Therapeutics 11/2023 - 09/2007
5	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 11/2002
3	Splenectomy 10/2022 - 11/2010
3	Blood Component Removal (Apheresis) 07/2013 - 01/2009
3	Stem Cell Transplantation 01/2009 - 11/2002
2	Blood Transfusion (Blood Transfusions) 11/2022 - 11/2010
2	Treatment Delay 01/2021 - 10/2013
2	Drug Tapering 01/2021 - 10/2013
2	Aftercare (After-Treatment) 01/2021 - 10/2009
2	Enzyme Replacement Therapy 01/2020 - 10/2011
2	Catheters 02/2005 - 01/2004
1	Anesthesia 11/2023